| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.637 | 25.249 | 294.357 | 451.546 | 614.307 |
| Total Income - EUR | - | - | - | - | - | 5.637 | 25.263 | 294.810 | 452.727 | 614.918 |
| Total Expenses - EUR | - | - | - | - | - | 4.555 | 18.004 | 214.741 | 372.827 | 511.707 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.083 | 7.259 | 80.069 | 79.900 | 103.211 |
| Net Profit/Loss - EUR | - | - | - | - | - | 927 | 6.592 | 74.787 | 75.372 | 85.022 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Alca Duo Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 42.787 | 61.304 | 141.837 |
| Current Assets | - | - | - | - | - | 953 | 24.157 | 85.384 | 103.910 | 80.140 |
| Inventories | - | - | - | - | - | 0 | 0 | 755 | 11.647 | 14.782 |
| Receivables | - | - | - | - | - | 3 | 22.956 | 47.494 | 55.835 | 49.380 |
| Cash | - | - | - | - | - | 951 | 1.201 | 37.135 | 36.428 | 15.978 |
| Shareholders Funds | - | - | - | - | - | 953 | 7.524 | 82.334 | 127.133 | 152.558 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 0 | 16.633 | 45.837 | 38.081 | 69.419 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Alca Duo Medical S.r.l.